{
    "paper_id": "3bb381a4d641c06aef82857dc12cf57f6df47a2a",
    "metadata": {
        "title": "Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19",
        "authors": [
            {
                "first": "Sebastiano",
                "middle": [
                    "Bruno"
                ],
                "last": "Solerte",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "\u00b7",
                "middle": [],
                "last": "Antonio",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Di",
                "middle": [],
                "last": "Sabatino",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "\u00b7",
                "middle": [
                    "Massimo"
                ],
                "last": "Galli",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Paolo",
                "middle": [],
                "last": "Fiorina",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Aims SARS-CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. Methods Virus binds to the cell surface receptor ACE2; indeed, recent evidences suggested that SARS-CoV-2 may be using as co-receptor, when entering the cells, the same one used by MERS-Co-V, namely the DPP4/CD26 receptor. The aforementioned observation underlined that mechanism of cell entry is supposedly similar among different coronavirus, that the co-expression of ACE2 and DPP4/CD26 could identify those cells targeted by different human coronaviruses and that clinical complications may be similar. Results The DPP4 family/system was implicated in various physiological processes and diseases of the immune system, and DPP4/CD26 is variously expressed on epithelia and endothelia of the systemic vasculature, lung, kidney, small intestine and heart. In particular, DPP4 distribution in the human respiratory tract may facilitate the entrance of the virus into the airway tract itself and could contribute to the development of cytokine storm and immunopathology in causing fatal COVID-19 pneumonia.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Conclusions The use of DPP4 inhibitors, such as gliptins, in patients with COVID-19 with, or even without, type 2 diabetes, may offer a simple way to reduce the virus entry and replication into the airways and to hamper the sustained cytokine storm and inflammation within the lung in patients diagnosed with COVID-19 infection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "The novel beta-coronavirus 2019 (SARS-CoV-2) has recently emerged as a threat for human kind, causing severe respiratory syndrome , associated with other systemic complications (i.e., intestinal infections, renal and heart failure) and with a relative high mortality [1] . This pathology has emerged from Wuhan City, in the China region of Hubei, and then spreading in Europe, Asia and USA [1] . This new pandemia follows the severe acute coronavirus respiratory syndrome of 2002-2003 (SARS-CoV), observed in the Guangdong Province of China and the Middle East respiratory syndrome coronavirus of 2012 (MERS-Co-V), mainly affecting the Arabian peninsula [1] .",
            "cite_spans": [
                {
                    "start": 267,
                    "end": 270,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 390,
                    "end": 393,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 654,
                    "end": 657,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Coronaviruses tropism is primarily determined by the ability of the spike (S) entry glycoprotein to bind to a cell surface receptor. It is well reported now that SARS-CoV-2 may use angiotensin-converting enzyme 2 (ACE2), the same receptor of SARS-CoV, to infect humans [2] . However, recent evidences demonstrated that SARS-CoV-2 binds to Managed by Massimo Federici. DPP4/CD26 when entering into cells of the respiratory tract [3] . It appears that the interaction between SARS-CoV-2 spike glycoprotein and the human DPP4/CD26, also known as dipeptidyl peptidase-4 (DPP4), is a key factor for the hijacking and virulence [3] . Interestingly, another recent study clearly reported a correlation between DPP4 and ACE2, suggesting that both membrane proteins are relevant in the pathogenesis of virus entry [4] . The co-expression of ACE2 and DPP4/CD26 as receptors of spike glycoproteins could hypothesize that different human coronaviruses (CoVs) target similar cell types across different human tissues and explain the presence of similar clinical features in patients infected with different CoVs. In another case, it was shown that DPP4 acted for CoV co-receptor, thus suggesting a potential similar mechanism of entry for SARS-CoV-2 [5] .",
            "cite_spans": [
                {
                    "start": 269,
                    "end": 272,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 428,
                    "end": 431,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 622,
                    "end": 625,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 805,
                    "end": 808,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1237,
                    "end": 1240,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP4), also known as CD26, is a widely expressed serine membrane-anchored ectopeptidase that exists on the surface of different cell types and cleaves dipeptides from the N-terminus, where a proline residue is in a penultimate position [6] . Besides its catalytic activity, DPP4 also acts as a binding protein and a ligand of extracellular factors and a large number of molecules can be cleaved by DPP4. This peptidase transmits intracellular signals through a small intracellular tail that cleave proline and more rapidly alanine and glycine [7, 8] . In particular, post-translational N-terminal hypersialylation may be implicated in DPP4 trafficking and virus aggressivity [9, 10] and, as already demonstrated in MERS-Co-V and porcine respiratory coronavirus, could involve the N-glycan binding interfaces of DPP4 [11] .",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 263,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 567,
                    "end": 570,
                    "text": "[7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 571,
                    "end": 573,
                    "text": "8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 699,
                    "end": 702,
                    "text": "[9,",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 703,
                    "end": 706,
                    "text": "10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 840,
                    "end": 844,
                    "text": "[11]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Clinical and experimental research over the past 30 years has clearly suggested that the DPP4/CD26 pathway is involved in various physiological processes and diseases of the immune system [12] ; not surprising for a molecule as CD26 that was originally described as a surface marker of T lymphocytes [13] . DPP4/CD26 transmembrane glycoprotein is not only expressed by various cells of the immune system, but also by epithelial and endothelial cells of systemic vasculature, by the endothelial cells of venules and capillaries, by the kidney, small intestine, lung, pancreas, spleen and heart, by the vascular smooth muscle cells, and by monocytes and hepatocytes and is soluble in the plasma [6, 7, 14] . In rats, lung appeared to be organ with the second highest expression of DDP4/CD26 [15] ; in particular, lung parenchyma, interstitium and pleural mesothelia were shown to be relative rich in DPP4 protein and are the lung area most affected by the CoVs-related injuries [16, 17] . The relation between DPP4/CD26 expression and site of CoVs-related injuries is overall well demonstrated in MERS-Co-V infection, where DPP4 could directly influence the kinetic of lung inflammation and may act itself as a proinflammatory signaling molecule [16, 18] . In COVID-19, although lacking of extensive pathological data, it appeared to be confirmed the aforementioned dynamic of correlation between DPP4/CD26 localization and site of lung inflammation [3] . Interestingly, both MERS-Co-V and SARS-CoV-2 predominantly infect lower airways and may cause acute respiratory distress syndrome (ARDS) and irreversible fatal pneumonia [17, 19, 20] . Furthermore, both SARS-CoV and MERS-Co-V are characterized by an important cytokine storm, with a similar immunopathology [21] . Virus infection and replication cause delayed interferon response, severe inflammatory monocyte macrophage and neutrophil infiltration and uncontrolled flood of proinflammatory cytokines and chemokines [22] . Moreover, there are evidences of diffuse vascular leakage, endothelial and epithelial apoptosis and of a diffuse microangiopathy with ischemic and thrombotic lesions that induce alveolar edema and collapse [22] . This may be a dramatic link between COVID-19 and diabetes, because the latter are more susceptible to abnormal coagulation and fibrinolysis, to impaired tissue remodeling and to multiorgan fibrosis and failure [23] [24] [25] [26] [27] . Taken together, all these findings clearly indicated that the aggressive impact of CoVs (SARS-CoV, MERS-Co-V and COVID-19) on tissues and organs is preferentially modulated, or least co-modulated, by DPP4/CD26 [28] and that DPP4/CD26 inhibition could antagonize this mechanism. DPP4/CD26 system modulation may be one of the new approaches to be employed for the pharmacologic treatment of COVID-19. The large amount of data available on the use of DPP4 inhibitors could support us to give a new strategic direction in COVID-19 treatment [6, 12, [29] [30] [31] [32] [33] . The pharmacological possibility to inhibit DPP4/CD26 activity by using commercial DPP4 inhibitors or gliptins (e.g., sitagliptin, linagliptin, vildagliptin and others) may represent a valid weapon to block the host CD26 receptor, thus disabling SARS-CoV-2 way to enter T cells [3, 34] . Along this line of investigation, we recently started at Sacco Hospital in Milan and at San Matteo Hospital in Pavia, the clinical trial SIDIACO (sitagliptin in diabetic patients with . SIDIACO is a case-control study, in which we will compare the clinical response of diabetic patients infected by COVID-19 during a 10 days course treatment with 100 mg Sitagliptin.",
            "cite_spans": [
                {
                    "start": 188,
                    "end": 192,
                    "text": "[12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 300,
                    "end": 304,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 693,
                    "end": 696,
                    "text": "[6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 697,
                    "end": 699,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 700,
                    "end": 703,
                    "text": "14]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 789,
                    "end": 793,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 976,
                    "end": 980,
                    "text": "[16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 981,
                    "end": 984,
                    "text": "17]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1244,
                    "end": 1248,
                    "text": "[16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1249,
                    "end": 1252,
                    "text": "18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1448,
                    "end": 1451,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1624,
                    "end": 1628,
                    "text": "[17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1629,
                    "end": 1632,
                    "text": "19,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1633,
                    "end": 1636,
                    "text": "20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1761,
                    "end": 1765,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1970,
                    "end": 1974,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 2183,
                    "end": 2187,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 2400,
                    "end": 2404,
                    "text": "[23]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 2405,
                    "end": 2409,
                    "text": "[24]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 2410,
                    "end": 2414,
                    "text": "[25]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 2415,
                    "end": 2419,
                    "text": "[26]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 2420,
                    "end": 2424,
                    "text": "[27]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 2637,
                    "end": 2641,
                    "text": "[28]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 2964,
                    "end": 2967,
                    "text": "[6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2968,
                    "end": 2971,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 2972,
                    "end": 2976,
                    "text": "[29]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 2977,
                    "end": 2981,
                    "text": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 2982,
                    "end": 2986,
                    "text": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 2987,
                    "end": 2991,
                    "text": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 2992,
                    "end": 2996,
                    "text": "[33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 3276,
                    "end": 3279,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 3280,
                    "end": 3283,
                    "text": "34]",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Several data suggested that the latter immune pharmacological activity of DDP4 seems to be independent of its catalytic activity [35] and for this reason unaffected by the use of inhibitors of the enzymatic activity of DPP4 [36] . Other scientific evidences supported that the use of DPP4/ CD26 inhibitors may act to antagonize airway inflammation [37] . DPP4 inhibition by gliptins may antagonize SARS-CoV-2 virulence and multiorgan acute and chronic damage by means of several additive mechanisms that involve: (1) reduction of cytokines overproduction [12, 30, 38, 39] ; (2) downregulation of macrophages activity/ function [40] ; (3) enhancement of GLP-1 anti-inflammatory activity [41, 42] , particularly in those aged patients with COVID-19 [43] ; (4) stimulation of direct pulmonary anti-inflammatory effects [44, 45] .",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 133,
                    "text": "[35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 224,
                    "end": 228,
                    "text": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 348,
                    "end": 352,
                    "text": "[37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 555,
                    "end": 559,
                    "text": "[12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 560,
                    "end": 563,
                    "text": "30,",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 564,
                    "end": 567,
                    "text": "38,",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 568,
                    "end": 571,
                    "text": "39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 627,
                    "end": 631,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 686,
                    "end": 690,
                    "text": "[41,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 691,
                    "end": 694,
                    "text": "42]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 747,
                    "end": 751,
                    "text": "[43]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 816,
                    "end": 820,
                    "text": "[44,",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 821,
                    "end": 824,
                    "text": "45]",
                    "ref_id": "BIBREF44"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "In summary, we hypothesize ( Fig. 1 ) that DPP4/CD26 inhibition with gliptins, and particularly with those with more highly selectivity for DPP4 [46, 47] , could represent a new strategy to support the treatment of COVID-19 in patients with or without diabetes.",
            "cite_spans": [
                {
                    "start": 145,
                    "end": 149,
                    "text": "[46,",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 150,
                    "end": 153,
                    "text": "47]",
                    "ref_id": "BIBREF46"
                }
            ],
            "ref_spans": [
                {
                    "start": 29,
                    "end": 35,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Introduction"
        },
        {
            "text": "Author contributions SBS, ADS, MG and PF designed and wrote the paper. All authors were given full access to all data presented in this study and are responsible for the integrity of the data and accuracy of the data analysis. All authors have given their permission for submission of this manuscript. Availability of data and material All data generated or analyzed during this study are available from the corresponding author on reasonable request.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Code availability Not applicable.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Conflict of interest The authors declare no present or potential conflicts of interest. This study was performed without the support or involvement of any external funding source or study sponsor in any phase of the investigation, or in the writing or submission of the manuscript. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Compliance with ethical standards"
        },
        {
            "text": "The participants provided informed consent for publication.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Consent to publish"
        },
        {
            "text": "Human and animal rights disclosure N/A.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Consent to publish"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Clinical characteristics of coronavirus disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "7798",
            "pages": "270--273",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Vankadari",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Wilce",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "1",
            "pages": "601--604",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Qi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Biochem Biophys Res Commun",
            "volume": "526",
            "issn": "1",
            "pages": "135--140",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bbrc.2020.03.044"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Raj",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nature",
            "volume": "495",
            "issn": "7440",
            "pages": "251--254",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Lambeir",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Crit Rev Clin Lab Sci",
            "volume": "40",
            "issn": "3",
            "pages": "209--294",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Dipeptidyl peptidase-IV inhibition for the treatment of cardiovascular disease-recent insights focusing on angiogenesis and neovascularization",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Circ J",
            "volume": "81",
            "issn": "6",
            "pages": "770--776",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Diabetes, hypertension, and chronic kidney disease progression: role of DPP4",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nistala",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Savin",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Am J Physiol Renal Physiol",
            "volume": "312",
            "issn": "4",
            "pages": "661--670",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Apical secretion and sialylation of soluble dipeptidyl peptidase IV are two related events",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Slimane",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Exp Cell Res",
            "volume": "258",
            "issn": "1",
            "pages": "184--194",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cuchacovich",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Clin Exp Rheumatol",
            "volume": "19",
            "issn": "6",
            "pages": "673--680",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nature",
            "volume": "500",
            "issn": "7461",
            "pages": "227--231",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Waumans",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Front Immunol",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Schon",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Biochem J",
            "volume": "223",
            "issn": "1",
            "pages": "255--258",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Durinx",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Eur J Biochem",
            "volume": "267",
            "issn": "17",
            "pages": "5608--5613",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schade",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Histochem Cytochem",
            "volume": "56",
            "issn": "2",
            "pages": "147--155",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the middle east respiratory syndrome",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Meyerholz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Lambertz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Mccray",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Am J Pathol",
            "volume": "186",
            "issn": "1",
            "pages": "78--86",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Zaki",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "N Engl J Med",
            "volume": "367",
            "issn": "",
            "pages": "1814--1820",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via proteaseactivated receptor 2",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wronkowitz",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Biochim Biophys Acta",
            "volume": "1842",
            "issn": "9",
            "pages": "1613--1621",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Identification of a novel coronavirus in patients with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Drosten",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1967--1976",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kuiken",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "9380",
            "pages": "263--270",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Immunopathol",
            "volume": "39",
            "issn": "5",
            "pages": "529--539",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Cell Host Microbe",
            "volume": "19",
            "issn": "2",
            "pages": "181--193",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "R"
                    ],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Mil Med Res",
            "volume": "7",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Embryonic stem cell extracts improve wound healing in diabetic mice",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Loretelli",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Acta Diabetol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s00592-020-01500-0"
                ]
            }
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidneypancreas transplantation",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Fiorina",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Diabetes",
            "volume": "53",
            "issn": "9",
            "pages": "2291--2300",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "D&apos;addio",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Cell Stem Cell",
            "volume": "17",
            "issn": "4",
            "pages": "486--498",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulindependent diabetic patients",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Astorri",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Clin Cardiol",
            "volume": "20",
            "issn": "6",
            "pages": "536--540",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kleine-Weber",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "1",
            "pages": "155--168",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "K"
                    ],
                    "last": "Hopsu-Havu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "G"
                    ],
                    "last": "Glenner",
                    "suffix": ""
                }
            ],
            "year": 1966,
            "venue": "Histochemie",
            "volume": "7",
            "issn": "3",
            "pages": "197--201",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Cut to the chase: a review of CD26/ dipeptidyl peptidase-4's (DPP4) entanglement in the immune system",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Klemann",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Clin Exp Immunol",
            "volume": "185",
            "issn": "1",
            "pages": "1--21",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Dipeptidyl peptidase-4 at the interface between inflammation and metabolism",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Trzaskalski",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fadzeyeva",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "E"
                    ],
                    "last": "Mulvihill",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Med Insights: Endocrinol Diabetes",
            "volume": "13",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network metaanalysis of 58 randomized controlled trials",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ling",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Acta Diabetol",
            "volume": "56",
            "issn": "3",
            "pages": "249--272",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ling",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Acta Diabetol",
            "volume": "56",
            "issn": "1",
            "pages": "7--27",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "The structure and function of CD26 in the T-cell immune response",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Morimoto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Schlossman",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Immunol Rev",
            "volume": "161",
            "issn": "",
            "pages": "55--70",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Molecular analysis of CD26-mediated signal transduction in T cells",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huhn",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Immunol Lett",
            "volume": "72",
            "issn": "2",
            "pages": "127--132",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Vora",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "BMC Immunol",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kruschinski",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Exp Immunol",
            "volume": "139",
            "issn": "1",
            "pages": "17--24",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Soluble CD26/dipeptidyl peptidase IV enhances the transcription of IL-6 and TNF-alpha in THP-1 cells and monocytes",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ikeda",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS ONE",
            "volume": "8",
            "issn": "6",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "SARS-CoV-2: a storm is raging",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Pedersen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Ho",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Invest",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1172/JCI137647"
                ]
            }
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARgamma",
            "authors": [
                {
                    "first": "Al-Qahtani",
                    "middle": [],
                    "last": "Aa",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Oncotarget",
            "volume": "8",
            "issn": "6",
            "pages": "9053--9066",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Diabetologia",
            "volume": "55",
            "issn": "9",
            "pages": "2456--2468",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Anti-inflammatory effects of GLP-1-based therapies beyond glucose control",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Jun",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mediators Inflamm",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1155/2016/3094642"
                ]
            }
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Dose rectification of an imbalance between DPP4 and GLP-1 ameliorates chronic stress-related vascular aging and atherosclerosis?",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "W"
                    ],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Clin Exp Pharmacol Physiol",
            "volume": "45",
            "issn": "5",
            "pages": "467--470",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kawasaki",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Am J Physiol Lung Cell Mol Physiol",
            "volume": "315",
            "issn": "5",
            "pages": "834--845",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Lab Invest",
            "volume": "98",
            "issn": "10",
            "pages": "1333--1346",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Deacon",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Lebovitz",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Diabetes Obes Metab",
            "volume": "18",
            "issn": "4",
            "pages": "333--347",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of Type 2 diabetes",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "F"
                    ],
                    "last": "Deacon",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Front Endocrinol",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Paolo Fiorina is supported by an Italian Ministry of Health Grant RF-2016-02362512 and by Linea-2 2019 funding from Universit\u00e0 di Milano. Paolo Fiorina is supported by Fondazione Romeo and Enrica Invernizzi.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Working hypothesis on the possible role of DPP4 inhibition (DPP4i) with gliptins to antagonize COVID-19 virulence and immunopathology Consent to participate N/A.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Stalk AA 48-29Site of action of DPP4inhibitors catalytic",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "Invernizzi for the extraordinary support.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgements We thank the Fondazione Romeo and Enrica"
        }
    ]
}